NASDAQ: NBIXNeurocrine Biosciences Inc Stock Ownership - Who owns Neurocrine Biosciences?
Insider buying vs selling
Have Neurocrine Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gary A. Lyons | Director | 2025-12-03 | 15,000 | $47.89 | $718.35kBuy |
| Gary A. Lyons | Director | 2025-12-03 | 15,000 | $152.61 | $2.29MSell |
| Jude Onyia | Chief Scientific Officer | 2025-11-29 | 2,248 | $152.16 | $342.06kSell |
| Eric Benevich | Chief Commercial Officer | 2025-11-28 | 5,970 | $151.74 | $905.88kSell |
| Eric Benevich | Chief Commercial Officer | 2025-11-28 | 5,970 | $35.99 | $214.86kBuy |
| George J. Morrow | Director | 2025-11-25 | 15,000 | $47.89 | $718.35kBuy |
| George J. Morrow | Director | 2025-11-25 | 15,000 | $143.37 | $2.15MSell |
| William H. Rastetter | Director | 2025-11-05 | 18,000 | $47.89 | $862.02kBuy |
| William H. Rastetter | Director | 2025-11-05 | 18,000 | $151.82 | $2.73MSell |
| Kyle Gano | Chief Executive Officer | 2025-11-04 | 300 | $141.97 | $42.59kSell |
NBIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NBIX insiders and whales buy or sell their stock.
NBIX Shareholders
What type of owners hold Neurocrine Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Partners L P | 35.16% | 35,058,600 | $5.45B | Insider |
| Blackrock Inc | 12.74% | 12,706,230 | $1.98B | Institution |
| Vanguard Group Inc | 9.74% | 9,706,559 | $1.51B | Institution |
| Dodge Cox | 5.57% | 5,556,618 | $864.11M | Institution |
| Jpmorgan Chase Co | 4.74% | 4,730,152 | $735.59M | Institution |
| State Street Corp | 4.36% | 4,346,479 | $675.92M | Institution |
| Price T Rowe Associates Inc | 2.88% | 2,866,731 | $445.81M | Institution |
| Aqr Capital Management LLC | 2.78% | 2,773,648 | $431.33M | Institution |
| Renaissance Technologies LLC | 2.43% | 2,418,297 | $376.07M | Institution |
| Geode Capital Management LLC | 2.03% | 2,024,825 | $314.88M | Institution |
NBIX vs Pharmaceutical Stocks
Neurocrine Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.